Fertility isn’t just about babies. According to Dr. Natalie Crawford on the Huberman Lab, it’s a window into a woman’s lifelong health - one that medicine is refusing to open early enough. Current guidelines wait for failure: a year of trying to conceive with no success before testing begins. Crawford calls this policy obsolete, even dangerous. A $79 AMH test can reveal ovarian reserve years before crisis hits - and change everything.
Women are not told that fecundability drops to 3% per month by age 40. Or that 72% of couples conceive in the first six months of trying - but only 13% after that. The data supports earlier intervention, especially for those over 35, yet ACOG still discourages AMH testing outside of clinical infertility. Crawford argues this gatekeeping leaves women blindsided, burning time they can’t recover.
"We should be testing ovarian reserve like we test cholesterol - preventively, not after the heart attack."
- Dr. Natalie Crawford, Huberman Lab
The stakes go beyond fertility. Infertility often signals systemic issues: insulin resistance, autoimmune disease, or chronic inflammation. Microplastics have been found accumulating in ovarian tissue, and endocrine disruptors are linked to lower IVF success. The ovary, Crawford notes, is a canary in the coal mine for metabolic and environmental toxicity.
Hormones aren’t just reproductive signals - they’re protective. Estrogen supports brain health, bone density, and cardiovascular function. Yet doctors wait for full menopause to intervene, using the term 'replacement' as if the system must fully collapse first. Crawford advocates for augmentation: supporting hormone levels earlier, especially in women with low-normal levels and debilitating symptoms.
"Perimenopause can last ten years. We’re telling women to suffer through it as normal aging - that’s medical gaslighting."
- Dr. Natalie Crawford, Huberman Lab
For women who’ve had prior pregnancies - even if lost - some fertility factors are already confirmed: sperm access, tubal patency, uterine receptivity. Yet two losses still trigger full evaluation. Crawford says one complicated loss may warrant earlier testing, including sperm fragmentation and uterine imaging. Egg quality - defined by chromosomal integrity and mitochondrial function - declines with age and metabolic stress. Waiting until 35 or 40 to act ignores the slow burn of oxidative damage.
